CQDM : Enable Drug Discovery

News about CQDM

CATALIS PRESENTS ITS NEW GENERAL MANAGER

July 21, 2017

CATALIS PRESENTS ITS NEW GENERAL MANAGER

New investment by GSK in CQDM to fund disruptive research announced at BIO

June 20, 2017

New investment by GSK in CQDM to fund disruptive research announced at BIO

June 20, 2017

The ESTI becomes CATALIS and benefits from an investment of $6.2 million to propel and promote Québec clinical trials

NEW PROGRAM: SYNERGIQC

May 23, 2017

NEW PROGRAM: SYNERGIQC

Relations recherche-industrie : des propos à nuancer

May 18, 2017

Relations recherche-industrie : des propos à nuancer

Upcoming Events

June 1, 2017

CQDM will attend to the 2017 BIO International Convention from June 4th to June 7th.

July 11, 2017

CALL FOR PROPOSALS SynergiQc and Quantum Leap : a new application period begins for these year-round programs!

July 24, 2017

Come meet CQDM at the Canada Talks Pharma event in Montreal on September 11-12.

In the Media

July 14, 2017

Ground-Braking Data Related to a Project Co-Funded by the CQDM to be Presented at the Alzheimer's Association International Conference, July 16-20th, 2017

All the
News

All
Events

Programs and
Competitions

All the Press
Articles